Surfactant palmitoylmyristoylphosphatidylcholine is a marker for alveolar size during disease.
about
Surfactant lipidomics in healthy children and childhood interstitial lung diseaseUpdate in pediatrics 2005.Update in pediatric lung disease 2006.Update in pediatric lung disease 2007.Ceramides: a potential therapeutic target in pulmonary emphysema.Pathophysiology of fatty acid oxidation disorders and resultant phenotypic variability.Intravenous and intratracheal mesenchymal stromal cell injection in a mouse model of pulmonary emphysemaMyristate is selectively incorporated into surfactant and decreases dipalmitoylphosphatidylcholine without functional impairment.Surfactant metabolism and anti-oxidative capacity in hyperoxic neonatal rat lungs: effects of keratinocyte growth factor on gene expression in vivo.Lipidomics of cellular and secreted phospholipids from differentiated human fetal type II alveolar epithelial cells.Alveolar-like Stem Cell-derived Myb(-) Macrophages Promote Recovery and Survival in Airway Disease.Differential effect of surfactant and its saturated phosphatidylcholines on human blood macrophages.rhKGF stimulates lung surfactant production in neonatal rats in vivo.Increased palmitoyl-myristoyl-phosphatidylcholine in neonatal rat surfactant is lung specific and correlates with oral myristic acid supplyQuantitative lipidomic analysis of mouse lung during postnatal development by electrospray ionization tandem mass spectrometry
P2860
Q35098582-7967DDF1-6097-4831-A3BE-58BCF335AC4EQ36416042-501F1D41-5F37-45CB-9A5C-B5E122666077Q36753133-E3316F7E-5D68-4C64-8CB1-510EEE78DA4FQ37117289-07611EC6-DCAD-45AD-A437-2B884CEAB62AQ37364329-1142A1B4-D311-4BF1-9DF6-053546A85C54Q38106893-641E0CE4-192B-4B46-9272-CF313448693EQ40354400-35CC88FA-ED3F-41DD-B78B-3DA8EE082C9BQ42920102-3C8147BA-A9FF-48C7-A8F5-986878C9F5F8Q44880447-DA0BD7CB-2154-47F3-9CDB-50A64A07D96FQ46973220-BDFC6E30-B223-43F3-820A-BC960DC2AE7AQ50541698-DE728F91-2516-40A9-A756-3A56734A6F8EQ50708380-9F53C58B-4BE5-4AD0-A0E2-EFC92D55D67CQ51481652-90E11A09-6FBD-48D0-A654-40F730DE1ADDQ56638879-EFB66DB9-F5D2-4ABE-99EA-6BC71D0259DDQ58760114-6430B6FC-EB2E-44EE-AAFD-3D310E7B4481
P2860
Surfactant palmitoylmyristoylphosphatidylcholine is a marker for alveolar size during disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Surfactant palmitoylmyristoylp ...... alveolar size during disease.
@en
Surfactant palmitoylmyristoylp ...... alveolar size during disease.
@nl
type
label
Surfactant palmitoylmyristoylp ...... alveolar size during disease.
@en
Surfactant palmitoylmyristoylp ...... alveolar size during disease.
@nl
prefLabel
Surfactant palmitoylmyristoylp ...... alveolar size during disease.
@en
Surfactant palmitoylmyristoylp ...... alveolar size during disease.
@nl
P2093
P2860
P1476
Surfactant palmitoylmyristoylp ...... alveolar size during disease.
@en
P2093
A Keith Tanswell
Frank D'Ovidio
Martin Post
Matthias Roth-Kleiner
Ross Ridsdale
Shaf Keshavjee
Sharon Unger
P2860
P304
P356
10.1164/RCCM.200501-109OC
P407
P577
2005-05-05T00:00:00Z